Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

CMXC Announces Additional Results of Preliminary Analysis of Metabolomic Assays
Wednesday, April 15, 2015
New findings reveal enhanced transport as well as utilization of glucose during a treatment.

MorphoSys to Receive Milestone Payment for Guselkumab Program
Tuesday, April 14, 2015
Company initiates phase 2 clinical trial in psoriatic arthritis with the HuCAL antibody.

ReNeuron Files Application to Commence Phase I/II Clinical Trial in the US
Tuesday, April 14, 2015
IND application to commence clinical trial for retinitis pigmentosa with hRPC therapy candidate.

ThromboGenics and VIB Launch New Oncology Company
Tuesday, April 14, 2015
Oncurious NV to develop TB-403 for pediatric brain tumors.

Cipher Acquires INNOCUTIS Holdings, Licensee of Sitavig® in the USA
Tuesday, April 14, 2015
Acquisition will further strengthen Sitavig®'s position.

PAREXEL Strengthens Commitment to Global Biopharmaceutical Workforce
Friday, April 10, 2015
Postgraduate certificate in clinical trial management offered in North America.

Santhera Receives FDA Fast Track Designation for Raxone®/Catena®
Friday, April 10, 2015
Fast Track designation for the treatment of Duchenne Muscular Dystrophy.

No Evidence to Change Current Transfusion Practices for Adults
Friday, April 10, 2015
Study found no difference in the primary clinical measure between complex cardiac surgery patients.

Merck and Pfizer Finalize Agreement to Co-Promote XALKORI®
Thursday, April 09, 2015
Co-promotion of XALKORI allows the alliance between Merck KGaA, Darmstadt, Germany, and Pfizer to establish a combined oncology sales organization in key markets for the program.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 3551

SELECTBIO Market Reports
Go to LabTube
Go to eposters